IRON Latest Headlines

Disc Medicine completes major common stock offering

at www.tipranks.com (Thu, 22-Oct 5:28 PM)

Disc Medicine prices a $450 million upsized stock offering at $75 as it funds bitopertin commercialization work

Market Chameleon (Wed, 21-Oct 8:38 AM)

Majority of Disc Medicine 6M share offering goes to 10 investors: report

at seekingalpha.com (Wed, 21-Oct 3:37 PM)

Disc Medicine sets $75 share price for $450M offering

at seekingalpha.com (Wed, 21-Oct 2:33 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: EyePoint Pharmaceuticals (EYPT), MannKind (MNKD) and Disc Medicine (IRON)

at www.tipranks.com (Tue, 20-Oct 7:50 AM)

IRON Jumps After Phase 3 APOLLO Trial Hits Every Primary and Secondary Endpoint for Bitopertin in EPP

Market Chameleon (Mon, 19-Oct 10:26 AM)

Disc Medicine (IRON) posts Phase 3 APOLLO win as bitopertin cuts PPIX 41.4% and adds 12.2 hours of pain-free light time

Market Chameleon (Mon, 19-Oct 7:06 AM)

Disc Medicine launches $350M public offering of common stock and pre-funded warrants

at seekingalpha.com (Mon, 19-Oct 4:15 PM)

Disc Medicine Stock (IRON) Soars Over 28% on a Phase 3 Trial Win

at www.tipranks.com (Mon, 19-Oct 11:19 AM)

Analysts Are Bullish on These Healthcare Stocks: Disc Medicine (IRON), Labcorp Holdings (LH)

at www.tipranks.com (Mon, 19-Oct 9:40 AM)

Biggest stock movers Monday: CLF, INTC, SPCX, and more

at seekingalpha.com (Mon, 19-Oct 9:24 AM)

Disc Medicine reports pivotal success in APOLLO bitopertin trial

at www.tipranks.com (Mon, 19-Oct 7:27 AM)

Disc Medicine surges on late-stage trial win for lead asset developed with Roche

at seekingalpha.com (Mon, 19-Oct 7:25 AM)

Disc Medicine posts late-stage trial win for lead asset developed with Roche

at seekingalpha.com (Mon, 19-Oct 7:25 AM)

Biggest stock movers Monday: INTC, SPCX, and more

at seekingalpha.com (Mon, 19-Oct 5:23 AM)